KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Non-Current Assets (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Non-Current Assets for 17 consecutive years, with $20.2 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 2.6% to $20.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82.2 billion through Dec 2025, down 2.97% year-over-year, with the annual reading at $20.2 billion for FY2025, 2.6% down from the prior year.
  • Non-Current Assets hit $20.2 billion in Q4 2025 for Bausch Health Companies, down from $20.6 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $24.8 billion in Q1 2021 to a low of $20.2 billion in Q4 2025.
  • Historically, Non-Current Assets has averaged $22.0 billion across 5 years, with a median of $21.5 billion in 2022.
  • Biggest five-year swings in Non-Current Assets: surged 553.89% in 2021 and later dropped 9.14% in 2022.
  • Year by year, Non-Current Assets stood at $23.6 billion in 2021, then fell by 9.14% to $21.4 billion in 2022, then increased by 1.47% to $21.8 billion in 2023, then dropped by 4.62% to $20.7 billion in 2024, then fell by 2.6% to $20.2 billion in 2025.
  • Business Quant data shows Non-Current Assets for BHC at $20.2 billion in Q4 2025, $20.6 billion in Q3 2025, and $20.8 billion in Q2 2025.